Chemed (NYSE:CHE) EVP Sells $494,196.40 in Stock

Chemed Corporation (NYSE:CHE) EVP Spencer Lee sold 920 shares of the company’s stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $537.17, for a total transaction of $494,196.40. Following the completion of the transaction, the executive vice president owned 13,931 shares in the company, valued at $7,483,315.27. This trade represents a 6.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Chemed Price Performance

Shares of Chemed stock opened at $533.43 on Friday. The company has a quick ratio of 1.08, a current ratio of 1.11 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $6.94 billion, a price-to-earnings ratio of 25.52, a price-to-earnings-growth ratio of 2.08 and a beta of 0.50. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $562.24. The company has a 50-day simple moving average of $514.34 and a two-hundred day simple moving average of $464.69.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 27th. The company reported $6.75 earnings per share for the quarter, beating analysts’ consensus estimates of $6.44 by $0.31. The company had revenue of $690.94 million during the quarter, compared to the consensus estimate of $685.04 million. Chemed had a net margin of 10.61% and a return on equity of 35.18%. The firm’s quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the business earned $5.27 earnings per share. Analysts forecast that Chemed Corporation will post 24.05 EPS for the current year.

Hedge Funds Weigh In On Chemed

Several large investors have recently bought and sold shares of CHE. Richardson Financial Services Inc. grew its position in Chemed by 5,700.0% in the 3rd quarter. Richardson Financial Services Inc. now owns 58 shares of the company’s stock worth $29,000 after purchasing an additional 57 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Chemed in the 2nd quarter valued at about $34,000. Versant Capital Management Inc lifted its position in shares of Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after buying an additional 75 shares in the last quarter. Keating Financial Advisory Services Inc. bought a new position in shares of Chemed during the 2nd quarter worth approximately $36,000. Finally, Fulcrum Asset Management LLP lifted its position in shares of Chemed by 121.9% during the 3rd quarter. Fulcrum Asset Management LLP now owns 71 shares of the company’s stock worth $36,000 after buying an additional 39 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on CHE shares. Oppenheimer boosted their price objective on shares of Chemed from $590.00 to $625.00 and gave the company an “outperform” rating in a research report on Thursday, October 29th. Royal Bank Of Canada raised their target price on Chemed from $548.00 to $585.00 and gave the company a “sector perform” rating in a report on Thursday, October 29th. UBS Group raised their target price on Chemed from $650.00 to $675.00 and gave the company a “buy” rating in a report on Thursday, October 29th. Bank of America reiterated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and upped their price objective for the stock from $520.00 to $620.00 in a research report on Wednesday, October 28th. Three equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, Chemed has an average rating of “Hold” and a consensus price target of $603.00.

About Chemed

Chemed Corporation (NYSE:CHE) is a Cincinnati, Ohio-based company that provides healthcare and residential and commercial services through two operating businesses: VITAS Healthcare and Roto-Rooter. Its operations serve customers primarily in the United States, with Roto-Rooter also providing services in Canada.

VITAS Healthcare is a provider of hospice and palliative care for individuals with advanced illnesses. The business delivers care in patients’ homes, hospice inpatient units, hospitals, nursing facilities and other care settings.